Hugo Martínez | Medicine | Breakthrough Research Award

Published on by International Popular Scientist Awards

Breakthrough Research Award

Hugo Martínez
Escuela Superior De Medicina

Hugo Martínez
Affiliation Escuela Superior De Medicina
Country Mexico
Scopus Id 25936565300
Documents 92
Citation 1,011
h-index 20
Subject Area Medicine
Event International PopularScientist Awards
Orcid 0000-0001-5161-5134

Hugo Martínez is a researcher affiliated with Escuela Superior De Medicina in Mexico whose documented scholarly output spans biomedical sensing, pharmaceutical materials, polymeric systems, nanomaterials, and related interdisciplinary research. The available bibliographic record identifies 92 documents, 1,011 citations, and an h-index of 20. Recent publications involving Hugo Martínez-Gutiérrez or Hugo Martínez Gutiérrez address biosensor development, controlled drug delivery, polymeric nanoparticles, sustainable materials, and photocatalytic systems, illustrating a research profile that connects medical and materials-oriented scientific questions.[1][2][3]

Abstract

This academic recognition profile presents the documented research activities associated with Hugo Martínez and his affiliation with Escuela Superior De Medicina, Mexico. The supplied bibliometric information records 92 documents, 1,011 citations, and an h-index of 20. Recent scholarly contributions include research on long-period fiber grating biosensors for interleukin-6 detection in murine serum, sustainable composite materials derived from pistachio shells, polymeric nanoparticles designed to interact with calcium and magnesium ions, cannabidiol encapsulation in polymeric hydrogels, and graphitic carbon nitride systems for photocatalytic applications.[1][2][3][4][5]

Keywords

Medicine; biomedical research; biosensors; interleukin-6 detection; ischemic disease; polymeric nanoparticles; pharmaceutical materials; controlled drug release; sustainable materials; photocatalysis; nanotechnology; interdisciplinary research.

Introduction

Contemporary medical and biomedical research increasingly integrates analytical sensing, materials science, nanotechnology, pharmaceutical engineering, and biological applications. Within this interdisciplinary environment, the documented publications associated with Hugo Martínez-Gutiérrez and related author records include studies addressing diagnostic sensing, biomaterials, drug-delivery systems, and functional nanomaterials. The research topics represented in the supplied publication record therefore extend beyond a single experimental platform while retaining connections to biomedical and applied scientific problems.[1][3][4]

Research Profile

The supplied research profile identifies Hugo Martínez with Escuela Superior De Medicina and the subject area of Medicine. The bibliometric information provided for this profile includes 92 documents, 1,011 citations, and an h-index of 20. These figures are presented as supplied profile data and should be interpreted in the context of the indexing platform, author-identification methodology, publication coverage, and date on which the metrics were retrieved.

Research Contributions

  • The study titled LPFG Biosensor for IL-6 Detection in Murine Serum Samples Associated with Ischemic Disease reports an application of long-period fiber grating sensing to the detection of interleukin-6 in murine serum samples and was published in Sensors.[1]
  • Research on pistachio-shell valorization examines the use of an agricultural by-product as a green composite material in the context of sustainable development.[2]
  • A study in Pharmaceuticals investigates polymeric nanoparticles with surface-anchored functional groups as chelating agents for calcium and magnesium ions and their potential role in inhibiting cellular interactions.[3]
  • A review in Gels examines cannabidiol encapsulation in polymeric hydrogels and controlled-release mechanisms, addressing formulation and delivery considerations.[4]
  • Research published in Catalysts evaluates comparative thermal and supramolecular hydrothermal synthesis of graphitic carbon nitride for photocatalytic degradation of gallic acid.[5]

Publications

The following selected publications are drawn from the supplied Crossref bibliographic records. Author names are reproduced according to the provided publication information, including variations in the presentation of the surname Martínez-Gutiérrez or Martínez Gutiérrez.

Research Impact

The supplied bibliometric record reports 1,011 citations across 92 documents and an h-index of 20. These indicators provide quantitative information about the visibility of the indexed publication record but do not by themselves measure the clinical, technological, societal, or translational significance of individual studies. Bibliometric values can also change as databases update records and citations.

Award Suitability

The documented publication record provides several research elements relevant to consideration for a Breakthrough Research Award, including a substantial indexed publication record, measurable citation activity, and research spanning biomedical sensing and functional materials. The selected studies also show participation in collaborative investigations involving biosensors, polymeric systems, pharmaceutical materials, sustainable composites, and photocatalysis.[1][2][3][4][5]

Conclusion

Hugo Martínez’s supplied academic profile describes a researcher associated with Escuela Superior De Medicina in Mexico and working within a publication portfolio that includes biomedical sensing, pharmaceutical materials, polymeric systems, sustainable composites, and photocatalytic materials. The provided record reports 92 documents, 1,011 citations, and an h-index of 20. Recent publications offer concrete examples of interdisciplinary research involving IL-6 biosensing, polymeric nanoparticles, controlled-release hydrogels, sustainable composite materials, and graphitic carbon nitride-based photocatalysis.[1][2][3][4][5]

References

  1. Vertti-Cervantes, Brenda; González-León, Karina; García-Juárez, Marcos; Beltrán-Pérez, Georgina; Montes-Narváez, Omar; López-Gayou, Valentín; González-Flores, Oscar; Martínez-Gutiérrez, Hugo; Delgado Macuil, Raúl Jacobo. (2026). LPFG Biosensor for IL-6 Detection in Murine Serum Samples Associated with Ischemic Disease. Sensors.
    https://doi.org/10.3390/s26092855
  2. Gutiérrez-Aldana, Natalia; Arzate-Vázquez, Israel; Méndez-Méndez, Juan Vicente; Martínez-Gutiérrez, Hugo; Chanona-Pérez, José Jorge. (2026). Valorization of pistachio shells as green composite material: an approach that contributes to sustainable development. Renewable Energy, Biomass & Sustainability.
    https://doi.org/10.56845/rebs.v8i1.672
  3. Ruiz-Virgen, Lazaro; Salazar-García, Juan Luis; Garduño-Wilches, Ismael Arturo; Rojas-López, Marlon; Martínez-Mejía, Gabriela; Caro-Briones, Rubén; Vázquez-Torres, Nadia A.; Castell-Rodríguez, Andrés; Martínez-Gutiérrez, Hugo; del Río, José Manuel et al. (2025). Polymeric Nanoparticles with Surface-Anchored Functional Groups as Chelating Agents for Calcium (Ca2+) and Magnesium (Mg2+) Ions to Inhibit Cellular Interactions. Pharmaceuticals.
    https://doi.org/10.3390/ph18121774
  4. Ovando-Medina, Víctor M.; García-Martínez, Carlos A.; Farias-Cepeda, Lorena; Antonio-Carmona, Iveth D.; Dector, Andrés; Olivares-Ramírez, Juan M.; Ortiz-Verdin, Alondra Anahí; Martínez-Gutiérrez, Hugo; Rivas Martínez, Erika Nohemi. (2025). Cannabidiol Encapsulation in Polymeric Hydrogels and Its Controlled Release: A Review. Gels.
    https://doi.org/10.3390/gels11100815
  5. Cantor Pérez, Fernando; Rodríguez Santillán, Julia Liliana; Santillán Peréz, Ricardo; Fuentes Camargo, Iliana; Romero Ibarra, Issis C.; Guzmán Castañeda, Jesús I.; Vazquez-Arce, Jorge L.; Tiznado, Hugo; Martínez Gutiérrez, Hugo. (2025). Comparative Thermal and Supramolecular Hydrothermal Synthesis of g-C3N4 Toward Efficient Photocatalytic Degradation of Gallic Acid. Catalysts.
    https://doi.org/10.3390/catal15090858

Isaac Egesa | Medicine | Best Researcher Award

Published on by International Popular Scientist Awards

Best Researcher Award

Isaac Egesa
University of Liverpool, United Kingdom

Isaac Egesa
Affiliation University of Liverpool
Country United Kingdom
Scopus ID 57354615500
Documents 6
Citations 35
h-index 3
Subject Area Medicine
Event International Popular Scientist Awards
ORCID 0000-0003-0483-1517

Isaac Egesa is a researcher affiliated with the University of Liverpool whose reported scholarly work is situated within medicine and clinical research methodology. His recent publications and research protocols address patient and public involvement and engagement, sequential multiple-assignment randomized trials, target trial emulation, focal epilepsy, evidence synthesis, and methodological standards for clinical research. His Scopus profile records six indexed documents, 35 citations, and an h-index of 3. [1]

Abstract

Isaac Egesa’s recent research record reflects an emerging focus on clinical research methodology and evidence-based medicine. His work includes investigations of patient and public involvement and engagement in sequential multiple-assignment randomized trials and target trial emulation, as well as systematic evidence synthesis concerning antiseizure medication strategies for focal epilepsy. His publications span journal articles, research protocols, and conference outputs published or disseminated between 2025 and 2026. [2] [3] [4]

Keywords

Isaac Egesa; Best Researcher Award; Medicine; Clinical Research; Evidence-Based Medicine; Sequential Multiple-Assignment Randomized Trials; Target Trial Emulation; Patient and Public Involvement; Focal Epilepsy; Systematic Review; Clinical Epidemiology; Research Methodology.

Introduction

Contemporary clinical research increasingly requires methodological approaches capable of addressing complex treatment decisions, longitudinal evidence, patient perspectives, and the limitations of conventional randomized trial designs. Sequential multiple-assignment randomized trials (SMARTs) and target trial emulation are among the approaches used to investigate adaptive treatment strategies and strengthen the design or interpretation of observational and experimental evidence. Egesa’s recent work engages with these methodological areas while also considering the role of patients and the public in the development and conduct of clinical research. [5]

Research Profile

The available research information places Egesa within the medicine and clinical epidemiology research environment at the University of Liverpool. His listed Scopus record contains six documents, 35 citations, and an h-index of 3. [1] The publication record supplied for this profile demonstrates activity across several interconnected methodological themes rather than a single narrowly defined clinical topic.

Research Contributions

A principal component of Egesa’s recent work concerns patient and public involvement and engagement (PPIE). His research examines how PPIE is represented within sequential multiple-assignment randomized trials and target trial emulation frameworks. These studies address methodological questions concerning how patients and members of the public can participate in research processes involving complex trial structures. [2] [4]

Publications

The supplied publication record includes peer-reviewed journal articles, preprints, research protocols, and a conference poster. The following list summarizes the reported works in chronological order from 2025 through 2026.

  1. The extent of Patient and Public Involvement and Engagement in Sequential Multiple Assignment Randomised Trials: a scoping Review. Journal of Clinical Epidemiology, 2026.Contributors include Isaac J. Egesa, Faye D. Baldwin, Molly Wells, Gashirai Mbizvo, Richard Emsley, Laura J. Bonnett, Emily Lam, Andrew Kightley, Anthony G. Marson, and Catrin Tudur Smith.
  2. The extent of Patient and Public Involvement and Engagement in Sequential Multiple Assignment Randomised Trials: a scoping Review. Preprint, 2026. SSRN.
  3. The effectiveness of adding on or switching antiseizure medications after the first fails to control focal epilepsy: A systematic review of randomized controlled trials. Epileptic Disorders, 2026.
  4. Patient and public involvement and engagement in target trial emulation framework: a scoping review protocol. BMJ Open, 2026.

Research Impact

The significance of Egesa’s research can be considered in relation to methodological development in clinical and epidemiological research. His work addresses questions about how complex treatment strategies can be studied, how patient and public perspectives can be incorporated into research frameworks, and how methodological reporting can support interpretation and reproducibility. [2] [5]

Award Suitability

Based on the information supplied for this profile, Egesa’s research record provides a reasonable basis for consideration within a Best Researcher Award category. The record demonstrates recent scholarly activity, peer-reviewed publication, methodological research, protocol development, and participation in collaborative research involving multiple investigators. The available bibliometric indicators also provide measurable evidence of scholarly dissemination through indexed documents and citations. [1]

Conclusion

Isaac Egesa’s recent scholarly output reflects a developing research profile in medicine with a particular emphasis on clinical research methodology, patient and public involvement, adaptive trial designs, target trial emulation, and evidence synthesis. His 2025–2026 publications and protocols demonstrate engagement with contemporary methodological challenges and clinically relevant research questions.

References

  1. Elsevier. (n.d.). Scopus author details: Isaac Egesa, Author ID 57354615500. Scopus.
    https://www.scopus.com/pages/authors/57354615500
  2. Egesa, I. J., Baldwin, F. D., Wells, M., Mbizvo, G., Emsley, R., Bonnett, L. J., Lam, E., Kightley, A., Marson, A. G., & Tudur Smith, C. (2026). The extent of Patient and Public Involvement and Engagement in Sequential Multiple Assignment Randomised Trials: a scoping Review. Journal of Clinical Epidemiology.
    DOI: 10.1016/j.jclinepi.2026.112455
  3. Egesa, I. J., et al. (2026). The extent of Patient and Public Involvement and Engagement in Sequential Multiple Assignment Randomised Trials: a scoping Review. Preprint. SSRN.
    DOI: 10.2139/ssrn.6502250
  4. Egesa, I. J., Baldwin, F. D., Wells, M., Maden, M., Mbizvo, G. K., Marson, A. G., & Tudur-Smith, C. (2026). Patient and public involvement and engagement in target trial emulation framework: a scoping review protocol. BMJ Open.
    DOI: 10.1136/bmjopen-2025-113432
  5. Egesa, I. J., Bonnett, L., Emsley, R., Marson, A., & Smith, C. T. (2026). A review of use of external data and update on reporting standards in Sequential Multiple-Assignment Randomised Trials. Clinical Trials.
    DOI: 10.1177/17407745251385535

Laurence Klotz | Medicine | Best Researcher Award

Published on by International Popular Scientist Awards

Best Researcher Award

Laurence Klotz
University of Toronto
           Laurence Klotz
Affiliation University of Toronto
Country Canada
Scopus ID 55040556500
Documents 598
Citations 33,603
h-index 87
Subject Area Medicine
Event International Popular Scientist Awards

Laurence Klotz  the Best Researcher Award recognizes distinguished scholars whose sustained scientific contributions, publication record, scholarly influence, and leadership have significantly advanced their respective disciplines. Laurence Klotz of the University of Toronto is internationally recognized for his extensive contributions to medicine, particularly in the field of urology and prostate cancer research. His scholarly productivity, citation impact, and leadership in clinical research demonstrate the qualities commonly associated with internationally recognized academic excellence.[1]

Abstract

Laurence Klotz has established an internationally respected academic profile through decades of clinical investigation, scholarly publication, and leadership within medicine. His research has focused extensively on prostate cancer diagnosis, management, active surveillance, and evidence-based clinical practice. A substantial publication portfolio and strong citation performance demonstrate the widespread influence of his scientific work across medical research communities.[1]

Keywords

Best Researcher Award, Laurence Klotz, University of Toronto, Medicine, Urology, Prostate Cancer, Clinical Research, Active Surveillance, Medical Innovation, Scientific Publications.

Introduction

Recognition through a Best Researcher Award generally reflects sustained scholarly productivity, innovation, research quality, international visibility, and measurable scientific impact. Laurence Klotz has contributed extensively to advancing evidence-based medicine through clinical investigations and peer-reviewed publications that have influenced patient management strategies and international clinical discussions.[2]

Research Profile

  • Institution: University of Toronto
  • Country: Canada
  • Primary Discipline: Medicine
  • Scopus Author ID: 55040556500
  • Indexed Documents: 598
  • Citation Count: 33,603
  • h-index: 87

Research Contributions

The research contributions of Laurence Klotz encompass clinical trials, translational medicine, evidence-based treatment strategies, and innovations in prostate cancer management. His investigations have supported advances in active surveillance protocols, patient risk stratification, biomarker evaluation, and improvements in clinical decision-making. These studies have contributed to contemporary understanding of disease progression while supporting safer and more personalized treatment pathways.[2]

Publications

  • Over 598 indexed scholarly publications in Scopus.
  • Research published in internationally recognized peer-reviewed medical journals.
  • Representative publication includes research related to active surveillance for prostate cancer.

Research Impact

A citation count exceeding thirty-three thousand together with an h-index of eighty-seven reflects broad scholarly recognition and sustained influence within the medical research community. Such bibliometric indicators demonstrate that published findings have been consistently referenced by researchers, clinicians, and guideline developers internationally.[1]

Award Suitability

Based on publicly available scholarly metrics and research accomplishments, Laurence Klotz demonstrates many characteristics commonly considered during evaluations for international academic recognition programs. These include sustained publication productivity, high citation impact, influential clinical research, interdisciplinary collaboration, scientific leadership, and measurable contributions to medical knowledge. Award decisions remain dependent upon the formal evaluation criteria established by the organizing committee of the International Popular Scientist Awards.[3]

Conclusion

Laurence Klotz has developed a distinguished international academic profile characterized by extensive publication activity, strong citation performance, and influential contributions to medicine. His research achievements, leadership within clinical science, and continued scholarly engagement illustrate the qualities frequently associated with internationally recognized research excellence and provide an informative example of academic achievement within the context of the Best Researcher Award.

References

  1. Elsevier. (n.d.). Scopus author details: Laurence Klotz, Author ID 55040556500. Scopus.
    https://www.scopus.com/pages/authors/55040556500
  2. Klotz, L. (2010). Active surveillance for favorable-risk prostate cancer. Journal of Clinical Oncology.
    DOI: https://doi.org/10.1200/JCO.2010.31.6951
  3. International Popular Scientist Awards. (n.d.). Award information and nomination guidelines.
    https://popularscientist.com/
  4. Kasivisvanathan, V., Rannikko, A. S., Borghi, M., Panebianco, V., Mynderse, L. A., Vaarala, M. H., Briganti, A., Budäus, L., Hellawell, G., Hindley, R. G., Roobol, M. J., Eggener, S., Gnanapragasam, V. J., Klotz, L., Taneja, S. S., George, A. K., Catalona, W. J., Hadaschik, B. A., Marks, L. S., … Emberton, M. (2018). MRI-targeted or standard biopsy for prostate-cancer diagnosis.

Maria Polikandrioti | Medicine | Innovative Research Award

Published on by International Popular Scientist Awards

Innovative Research Award

          Maria Polikandrioti
Affiliation University of West Attica
Country Greece
Scopus ID 27567900200
Documents 110
Citations 1,163
h-index 19
Subject Area Medicine
Event International Popular Scientist Awards

Maria Polikandrioti

University of West Attica, Greece

Maria Polikandrioti the Innovative Research Award recognizes distinguished scholarly achievements that demonstrate sustained research excellence, scientific productivity, and meaningful contributions to academic knowledge. Maria Polikandrioti has established an active research profile in the field of medicine through peer-reviewed publications, interdisciplinary collaborations, and contributions to healthcare research. Her scholarly record, reflected through indexed publications, citations, and research impact metrics, demonstrates continued engagement with evidence-based medical science and academic advancement.[1]

Abstract

Maria Polikandrioti has contributed to medical research through publications addressing clinical practice, nursing science, patient outcomes, and healthcare quality improvement. Her academic work demonstrates consistent participation in internationally indexed research and emphasizes evidence-based healthcare approaches. Bibliometric indicators, including 110 indexed documents, 1,163 citations, and an h-index of 19, illustrate measurable scholarly influence within the medical research community.[1]

Keywords

Medicine, Nursing Research, Clinical Research, Healthcare Quality, Evidence-Based Practice, Patient Care, Medical Publications, Research Impact.

Introduction

Modern healthcare research relies upon rigorous scientific investigation to improve patient outcomes, strengthen clinical decision-making, and support public health initiatives. Researchers with sustained publication records contribute significantly to expanding medical knowledge through collaborative investigations, systematic analysis, and dissemination of validated findings. Maria Polikandrioti’s academic profile reflects continued involvement in these objectives through research published in internationally recognized journals.[1]

Research Profile

Affiliated with the University of West Attica, Maria Polikandrioti maintains an established research portfolio within the discipline of medicine. Her Scopus author profile documents extensive scholarly activity comprising 110 indexed publications supported by over one thousand citations and an h-index of 19, indicating sustained visibility and influence within academic literature.[1]

Research Contributions

Research focuses on nursing science, clinical healthcare, and evidence-based practice, with publications addressing patient care, quality of life, and health outcomes. Through multidisciplinary healthcare research and contributions to peer-reviewed international medical literature, this work supports advancements in clinical practice and improved healthcare delivery.

Publications

Maria Polikandrioti has authored and co-authored numerous scientific publications indexed in major international databases. Her research covers clinical nursing, chronic disease management, patient-centered care, quality assessment, and healthcare delivery. Several publications include Digital Object Identifiers (DOIs), facilitating permanent access, citation tracking, and long-term scholarly visibility.[2]

Research Impact

Bibliometric indicators demonstrate consistent academic engagement and measurable scientific influence. The combination of indexed publications, citation performance, and a stable h-index reflects ongoing recognition by the research community. These indicators support the visibility of her work across medical and healthcare disciplines while illustrating sustained scholarly productivity.[1]

Award Suitability

Maria Polikandrioti’s academic achievements align with the objectives of the International Popular Scientist Awards by demonstrating continuous scientific productivity, international publication activity, measurable research impact, and contributions to advancing medical knowledge. Her established research profile illustrates qualities commonly associated with scholarly recognition based upon scientific merit, academic consistency, and evidence-based healthcare research.[3]

Conclusion

Maria Polikandrioti represents an active contributor to contemporary medical research through sustained publication, collaborative scholarship, and measurable bibliometric performance. Her academic record reflects continued dedication to improving healthcare knowledge and supporting evidence-based clinical practice, making her research profile appropriate for consideration within international scientific recognition initiatives.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Maria Polikandrioti, Author ID 27567900200. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=27567900200
  2. Crossref. (Various years). Peer-reviewed medical publications indexed with Digital Object Identifiers (DOIs).
  3. International Popular Scientist Awards. (n.d.). Award information and nomination criteria.
    https://popularscientist.com/
  4. Gerasimoula, K., Lefkothea, L., Maria, L., Victoria, A., Paraskevi, T., & Polikandrioti, M. (2015). Quality of life in hemodialysis patients.